nodes	percent_of_prediction	percent_of_DWPC	metapath
Spironolactone—SHBG—hindlimb—amyotrophic lateral sclerosis	0.0431	0.139	CbGeAlD
Spironolactone—Breast pain—Riluzole—amyotrophic lateral sclerosis	0.023	0.0805	CcSEcCtD
Spironolactone—Amenorrhoea—Riluzole—amyotrophic lateral sclerosis	0.0228	0.0799	CcSEcCtD
Spironolactone—Ulcer—Riluzole—amyotrophic lateral sclerosis	0.0212	0.0742	CcSEcCtD
Spironolactone—SHBG—hindbrain—amyotrophic lateral sclerosis	0.0196	0.0633	CbGeAlD
Spironolactone—NR3C2—hindbrain—amyotrophic lateral sclerosis	0.019	0.0613	CbGeAlD
Spironolactone—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.0184	0.0645	CcSEcCtD
Spironolactone—PGR—hindbrain—amyotrophic lateral sclerosis	0.0177	0.057	CbGeAlD
Spironolactone—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.0137	0.0479	CcSEcCtD
Spironolactone—NR3C1—nerve—amyotrophic lateral sclerosis	0.0136	0.0439	CbGeAlD
Spironolactone—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.0129	0.0451	CcSEcCtD
Spironolactone—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.0116	0.0406	CcSEcCtD
Spironolactone—SHBG—brainstem—amyotrophic lateral sclerosis	0.0112	0.0363	CbGeAlD
Spironolactone—NR3C2—brainstem—amyotrophic lateral sclerosis	0.0109	0.0352	CbGeAlD
Spironolactone—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.0105	0.0367	CcSEcCtD
Spironolactone—NR3C1—hindbrain—amyotrophic lateral sclerosis	0.0102	0.0329	CbGeAlD
Spironolactone—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00952	0.0333	CcSEcCtD
Spironolactone—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.0089	0.0312	CcSEcCtD
Spironolactone—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00843	0.0295	CcSEcCtD
Spironolactone—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00814	0.0285	CcSEcCtD
Spironolactone—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00791	0.0277	CcSEcCtD
Spironolactone—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00785	0.0275	CcSEcCtD
Spironolactone—NR3C2—medulla oblongata—amyotrophic lateral sclerosis	0.0076	0.0245	CbGeAlD
Spironolactone—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00738	0.0258	CcSEcCtD
Spironolactone—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00722	0.0253	CcSEcCtD
Spironolactone—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00716	0.0251	CcSEcCtD
Spironolactone—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00701	0.0245	CcSEcCtD
Spironolactone—NR3C2—spinal cord—amyotrophic lateral sclerosis	0.00678	0.0219	CbGeAlD
Spironolactone—SLCO1A2—medulla oblongata—amyotrophic lateral sclerosis	0.00651	0.021	CbGeAlD
Spironolactone—NR3C1—embryo—amyotrophic lateral sclerosis	0.00638	0.0206	CbGeAlD
Spironolactone—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00636	0.0223	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00618	0.0216	CcSEcCtD
Spironolactone—Progesterone—SIGMAR1—amyotrophic lateral sclerosis	0.00592	0.722	CrCbGaD
Spironolactone—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.0059	0.0206	CcSEcCtD
Spironolactone—NR3C1—brainstem—amyotrophic lateral sclerosis	0.00585	0.0189	CbGeAlD
Spironolactone—SLCO1A2—spinal cord—amyotrophic lateral sclerosis	0.00581	0.0187	CbGeAlD
Spironolactone—NR3C2—nervous system—amyotrophic lateral sclerosis	0.00571	0.0184	CbGeAlD
Spironolactone—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00568	0.0199	CcSEcCtD
Spironolactone—SHBG—central nervous system—amyotrophic lateral sclerosis	0.00567	0.0183	CbGeAlD
Spironolactone—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00566	0.0198	CcSEcCtD
Spironolactone—SHBG—cerebellum—amyotrophic lateral sclerosis	0.00554	0.0179	CbGeAlD
Spironolactone—NR3C2—central nervous system—amyotrophic lateral sclerosis	0.0055	0.0177	CbGeAlD
Spironolactone—NR3C2—cerebellum—amyotrophic lateral sclerosis	0.00537	0.0173	CbGeAlD
Spironolactone—PGR—nervous system—amyotrophic lateral sclerosis	0.00531	0.0171	CbGeAlD
Spironolactone—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00527	0.0185	CcSEcCtD
Spironolactone—PGR—central nervous system—amyotrophic lateral sclerosis	0.00511	0.0165	CbGeAlD
Spironolactone—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00506	0.0177	CcSEcCtD
Spironolactone—AR—spinal cord—amyotrophic lateral sclerosis	0.00502	0.0162	CbGeAlD
Spironolactone—PGR—cerebellum—amyotrophic lateral sclerosis	0.00499	0.0161	CbGeAlD
Spironolactone—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.0049	0.0171	CcSEcCtD
Spironolactone—SLCO1A2—nervous system—amyotrophic lateral sclerosis	0.00489	0.0158	CbGeAlD
Spironolactone—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00473	0.0166	CcSEcCtD
Spironolactone—SLCO1A2—central nervous system—amyotrophic lateral sclerosis	0.00471	0.0152	CbGeAlD
Spironolactone—SLCO1A2—cerebellum—amyotrophic lateral sclerosis	0.00461	0.0149	CbGeAlD
Spironolactone—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00455	0.0159	CcSEcCtD
Spironolactone—Rash—Riluzole—amyotrophic lateral sclerosis	0.00451	0.0158	CcSEcCtD
Spironolactone—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00451	0.0158	CcSEcCtD
Spironolactone—SHBG—brain—amyotrophic lateral sclerosis	0.0045	0.0145	CbGeAlD
Spironolactone—Headache—Riluzole—amyotrophic lateral sclerosis	0.00448	0.0157	CcSEcCtD
Spironolactone—NR3C2—brain—amyotrophic lateral sclerosis	0.00436	0.0141	CbGeAlD
Spironolactone—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00425	0.0149	CcSEcCtD
Spironolactone—AR—nervous system—amyotrophic lateral sclerosis	0.00423	0.0136	CbGeAlD
Spironolactone—NR3C1—medulla oblongata—amyotrophic lateral sclerosis	0.00408	0.0131	CbGeAlD
Spironolactone—AR—central nervous system—amyotrophic lateral sclerosis	0.00407	0.0131	CbGeAlD
Spironolactone—PGR—brain—amyotrophic lateral sclerosis	0.00406	0.0131	CbGeAlD
Spironolactone—SLCO1A2—brain—amyotrophic lateral sclerosis	0.00374	0.0121	CbGeAlD
Spironolactone—NR3C1—spinal cord—amyotrophic lateral sclerosis	0.00363	0.0117	CbGeAlD
Spironolactone—ABCB1—embryo—amyotrophic lateral sclerosis	0.00341	0.011	CbGeAlD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00333	0.0084	CbGpPWpGaD
Spironolactone—PGR—Validated nuclear estrogen receptor alpha network—SOD1—amyotrophic lateral sclerosis	0.00325	0.00821	CbGpPWpGaD
Spironolactone—AR—brain—amyotrophic lateral sclerosis	0.00323	0.0104	CbGeAlD
Spironolactone—CYP11B1—Corticotropin-releasing hormone—CASP9—amyotrophic lateral sclerosis	0.00314	0.00792	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.00308	0.00776	CbGpPWpGaD
Spironolactone—NR3C1—nervous system—amyotrophic lateral sclerosis	0.00306	0.00988	CbGeAlD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00304	0.00768	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—GFAP—amyotrophic lateral sclerosis	0.00299	0.00755	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.00296	0.00748	CbGpPWpGaD
Spironolactone—NR3C1—central nervous system—amyotrophic lateral sclerosis	0.00295	0.00951	CbGeAlD
Spironolactone—PGR—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.00295	0.00744	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.00291	0.00735	CbGpPWpGaD
Spironolactone—NR3C1—cerebellum—amyotrophic lateral sclerosis	0.00288	0.0093	CbGeAlD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00287	0.00724	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00283	0.00714	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00266	0.00671	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00262	0.00662	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.00261	0.0066	CbGpPWpGaD
Spironolactone—CYP2C8—brain—amyotrophic lateral sclerosis	0.00261	0.00843	CbGeAlD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.0026	0.00656	CbGpPWpGaD
Spironolactone—PGR—Validated nuclear estrogen receptor alpha network—C3—amyotrophic lateral sclerosis	0.00258	0.00651	CbGpPWpGaD
Spironolactone—NR3C2—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.00254	0.00642	CbGpPWpGaD
Spironolactone—ABCC2—NRF2 pathway—GSR—amyotrophic lateral sclerosis	0.00246	0.0062	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—RARA—amyotrophic lateral sclerosis	0.00245	0.00619	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00244	0.00615	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.00238	0.006	CbGpPWpGaD
Spironolactone—NR3C1—brain—amyotrophic lateral sclerosis	0.00234	0.00755	CbGeAlD
Spironolactone—NR3C2—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.00233	0.00588	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00229	0.00579	CbGpPWpGaD
Spironolactone—Drospirenone—PTGS2—amyotrophic lateral sclerosis	0.00228	0.278	CrCbGaD
Spironolactone—NR3C1—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.00225	0.00568	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.00225	0.00567	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.00221	0.00557	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.00221	0.00557	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.00221	0.00557	CbGpPWpGaD
Spironolactone—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.00218	0.00704	CbGeAlD
Spironolactone—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.00195	0.00628	CbGeAlD
Spironolactone—CYP11B2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.00193	0.00488	CbGpPWpGaD
Spironolactone—CYP11B2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.00191	0.00481	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.00187	0.00473	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00182	0.0046	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—CASP9—amyotrophic lateral sclerosis	0.00182	0.00458	CbGpPWpGaD
Spironolactone—ABCC2—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.0018	0.00454	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.0018	0.00454	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.0017	0.0043	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.00167	0.00423	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.00167	0.00423	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.00167	0.00423	CbGpPWpGaD
Spironolactone—CYP11B1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.00167	0.00421	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00164	0.00415	CbGpPWpGaD
Spironolactone—CYP11B1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.00164	0.00415	CbGpPWpGaD
Spironolactone—SLCO1A2—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00164	0.00415	CbGpPWpGaD
Spironolactone—ABCB1—nervous system—amyotrophic lateral sclerosis	0.00164	0.00529	CbGeAlD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.00163	0.00412	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.00162	0.00408	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.00159	0.00402	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.00158	0.004	CbGpPWpGaD
Spironolactone—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.00158	0.00509	CbGeAlD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00157	0.00397	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—ERBB4—amyotrophic lateral sclerosis	0.00155	0.00392	CbGpPWpGaD
Spironolactone—PGR—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.00155	0.00391	CbGpPWpGaD
Spironolactone—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.00154	0.00498	CbGeAlD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00153	0.00386	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—FUS—amyotrophic lateral sclerosis	0.0015	0.00379	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.00149	0.00377	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00148	0.00374	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00148	0.00374	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—ATF1—amyotrophic lateral sclerosis	0.00146	0.00369	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.00145	0.00367	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00144	0.00363	CbGpPWpGaD
Spironolactone—AR—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.00143	0.0036	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.00142	0.00358	CbGpPWpGaD
Spironolactone—SLCO1A2—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.0014	0.00353	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.00139	0.00351	CbGpPWpGaD
Spironolactone—ABCC2—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.00139	0.0035	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.00138	0.00349	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00136	0.00342	CbGpPWpGaD
Spironolactone—CYP11B1—Corticotropin-releasing hormone—CASP3—amyotrophic lateral sclerosis	0.00132	0.00334	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.0013	0.00327	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00128	0.00322	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00128	0.00322	CbGpPWpGaD
Spironolactone—CYP2C8—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00127	0.0032	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00126	0.00318	CbGpPWpGaD
Spironolactone—ABCB1—brain—amyotrophic lateral sclerosis	0.00125	0.00404	CbGeAlD
Spironolactone—SLCO1A2—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00124	0.00314	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—RARA—amyotrophic lateral sclerosis	0.00122	0.00309	CbGpPWpGaD
Spironolactone—AR—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.00121	0.00306	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.00119	0.00301	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.00119	0.003	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00118	0.00299	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.00118	0.00298	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00118	0.00298	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00117	0.00295	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.00115	0.00291	CbGpPWpGaD
Spironolactone—CYP2C8—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00115	0.0029	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.00114	0.00288	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00109	0.00274	CbGpPWpGaD
Spironolactone—ABCC2—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.00108	0.00274	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.00108	0.00273	CbGpPWpGaD
Spironolactone—AR—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.00108	0.00273	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—DAO—amyotrophic lateral sclerosis	0.00107	0.0027	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00102	0.00258	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000985	0.00249	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.000984	0.00248	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000971	0.00245	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.000968	0.00244	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—CASP9—amyotrophic lateral sclerosis	0.000952	0.0024	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000927	0.00234	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000923	0.00233	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.000921	0.00232	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—amyotrophic lateral sclerosis	0.00092	0.00232	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—FUS—amyotrophic lateral sclerosis	0.000915	0.00231	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.000895	0.00226	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.000886	0.00224	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000883	0.00223	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000867	0.00219	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000835	0.00211	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.00082	0.00207	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000812	0.00205	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000808	0.00204	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000801	0.00202	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000801	0.00202	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—MMP9—amyotrophic lateral sclerosis	0.000777	0.00196	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	0.000766	0.00193	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00076	0.00192	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000751	0.0019	CbGpPWpGaD
Spironolactone—AR—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.00075	0.00189	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—GSR—amyotrophic lateral sclerosis	0.000749	0.00189	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000746	0.00188	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—RARA—amyotrophic lateral sclerosis	0.000746	0.00188	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000732	0.00185	CbGpPWpGaD
Spironolactone—CYP2C8—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000715	0.0018	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00071	0.00179	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00071	0.00179	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000706	0.00178	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.0007	0.00177	CbGpPWpGaD
Spironolactone—AR—Gene Expression—FUS—amyotrophic lateral sclerosis	0.000697	0.00176	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000682	0.00172	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000681	0.00172	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—C3—amyotrophic lateral sclerosis	0.000677	0.00171	CbGpPWpGaD
Spironolactone—AR—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.000675	0.0017	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.000666	0.00168	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—IGF1—amyotrophic lateral sclerosis	0.000651	0.00164	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000646	0.00163	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000646	0.00163	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000646	0.00163	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000646	0.00163	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00064	0.00162	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000633	0.0016	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.00063	0.00159	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000615	0.00155	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000608	0.00153	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000588	0.00148	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000586	0.00148	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—DAO—amyotrophic lateral sclerosis	0.000579	0.00146	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000576	0.00145	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000571	0.00144	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.000569	0.00144	CbGpPWpGaD
Spironolactone—AR—Gene Expression—RARA—amyotrophic lateral sclerosis	0.000568	0.00143	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000561	0.00142	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000555	0.0014	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.00053	0.00134	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—FUS—amyotrophic lateral sclerosis	0.000529	0.00133	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—TP53—amyotrophic lateral sclerosis	0.000527	0.00133	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000523	0.00132	CbGpPWpGaD
Spironolactone—CYP2C8—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000513	0.0013	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.000512	0.00129	CbGpPWpGaD
Spironolactone—CYP2C8—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000506	0.00128	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000506	0.00128	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000497	0.00125	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000485	0.00122	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000484	0.00122	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000484	0.00122	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000484	0.00122	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000475	0.0012	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.00047	0.00119	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—TP53—amyotrophic lateral sclerosis	0.000464	0.00117	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000451	0.00114	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000439	0.00111	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000437	0.0011	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000433	0.00109	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—RARA—amyotrophic lateral sclerosis	0.000431	0.00109	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000412	0.00104	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GSR—amyotrophic lateral sclerosis	0.000405	0.00102	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	0.000401	0.00101	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000396	0.000999	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000393	0.000993	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000393	0.000993	CbGpPWpGaD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	0.000393	0.000991	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000388	0.000978	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000385	0.000971	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000383	0.000967	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000378	0.000954	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000376	0.000948	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000369	0.000931	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000367	0.000927	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000367	0.000926	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00036	0.000908	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000357	0.000902	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000343	0.000865	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000343	0.000865	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	0.00034	0.000859	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000335	0.000844	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000332	0.000839	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000331	0.000837	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000331	0.000835	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000315	0.000794	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000313	0.000791	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000311	0.000785	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000304	0.000767	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000304	0.000767	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000304	0.000767	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000303	0.000766	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000291	0.000736	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000285	0.000719	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	0.000284	0.000718	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000274	0.000692	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000271	0.000684	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000263	0.000665	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000262	0.000661	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000257	0.000649	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—APOE—amyotrophic lateral sclerosis	0.00025	0.000631	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000248	0.000625	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000247	0.000623	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000235	0.000594	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000216	0.000544	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—APOE—amyotrophic lateral sclerosis	0.000215	0.000544	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000213	0.000538	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000208	0.000525	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000201	0.000508	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	0.000199	0.000502	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000198	0.000499	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000189	0.000478	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000188	0.000474	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000181	0.000457	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000179	0.000451	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000173	0.000437	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000171	0.000432	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000168	0.000424	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000167	0.000422	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000164	0.000414	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000163	0.000412	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000156	0.000393	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000149	0.000376	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000148	0.000373	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000142	0.000359	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—APOE—amyotrophic lateral sclerosis	0.000135	0.000341	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000129	0.000325	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000127	0.00032	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000102	0.000258	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	9.91e-05	0.00025	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	9.36e-05	0.000236	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.26e-05	0.000234	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.78e-05	0.000222	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	8.41e-05	0.000212	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.07e-05	0.000204	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.65e-05	0.000193	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.03e-05	0.000177	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	6.64e-05	0.000168	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.35e-05	0.00016	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	5.78e-05	0.000146	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.55e-05	0.000115	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.96e-05	0.0001	CbGpPWpGaD
